atenolol has been researched along with Idiopathic Parkinson Disease in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Liu, G | 1 |
| Chen, J | 1 |
| Reddy, PS | 1 |
| Yoon, IS | 1 |
| Zhang, M | 1 |
| Zhang, B | 1 |
| Barber, JR | 1 |
| Ng, SC | 1 |
| Barajas García-Talavera, F | 1 |
| Rodríguez Díaz, M | 1 |
| Pérez de Paz, A | 1 |
2 other studies available for atenolol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione derivatives: their cytoprotection effect from rotenone toxicity and preliminary DMPK properties.
Topics: Animals; Cytoprotection; Insecticides; Male; Microsomes, Liver; Parkinson Disease; Rats; Rotenone; S | 2009 |
[Atenolol in the control of parkinsonian tremor].
Topics: Atenolol; Humans; Male; Middle Aged; Parkinson Disease | 1985 |